Skip Navigation

Cardiovascular Research 2004 63(3):414-422; doi:10.1016/j.cardiores.2004.04.022
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Pepe, S.
Right arrow Articles by Xiao, R.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pepe, S.
Right arrow Articles by Xiao, R.-P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Cross-talk of opioid peptide receptor and β-adrenergic receptor signalling in the heart

Salvatore Pepea,b, Olivier W.V van den Brinka, Edward G Lakattab and Rui-Ping Xiao*,b,c

aLaboratory of Cardiac Surgical Research, Wynn Domain, Baker Heart Research Institute and The Alfred Hospital, Monash University Faculty of Medicine, Melbourne, Australia
bLaboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA
cThe Institute of Molecular Medicine and The Institute of Cardiovascular Sciences, Peking University, Beijing 100871, People's Republic of China

* Corresponding author. Laboratory of Cardiovascular Science, Gerontology Research Center, National Institute on Aging, NIH, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA. Tel.: +1-410-558-8662; fax: +1-410-558-8150. Email address: xiaor{at}grc.nia.nih.gov

Opioid peptide receptor (OPR) and β-adrenergic receptor (β-AR) are well-established members of G-protein-coupled receptor (GPCR) superfamily and are involved in regulating cardiac contractility, energy metabolism, myocyte survival or death. OPRs are typical Gi/Go-coupled receptors and activated by opioid peptides derived from the endorphin, dynorphin and enkephalin families, whereas β-AR stimulated by catecholamines is the model system for Gs-coupled receptors. While it is widely accepted that β-AR stimulation serves as the most powerful means to increase cardiac output in response to stress or exercise, we have only begun to appreciate functional roles of OPR stimulation in regulating cardiovascular performance. Cardiovascular regulatory effects of endogenous opioids were initially considered to originate from the central nervous system and involved the pre-synaptic co-release of norepinephrine with enkephalin from sympathetic neuronal terminals in the heart. However, opioid peptides of myocardial origin have been shown to play important roles in local regulation of the heart. Notably, OPR stimulation not only inhibits cardiac excitation–contraction coupling, but also protects the heart against hypoxic and ischemic injury via activation of Gi-mediated signalling pathways. Further, OPRs functionally and physically cross-talk with β-ARs via multiple hierarchical mechanisms, including heterodimerization of these receptors, counterbalance of functional opposing G protein signalling, and interface at downstream signalling events. As a result, the β-AR-mediated positive inotropic effect and increase in cAMP are markedly attenuated by OPR activation in isolated cardiomyocytes as well as sympathectomized intact rat hearts. This brief review will focus on the interaction between β-AR and OPR and its potential physiological and pathophysiological relevance in the heart.

KEYWORDS G protein-coupled receptors; β-Adrenergic receptors; Opioid peptide receptors; Receptor dimerization; Cardiac contractility; Cardiac preconditioning


Time for primary review 21 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Bolte, G. Newman, and J. E. J. Schultz
Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac {kappa}-opioid receptor stimulation
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H967 - H975.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
O. W. van den Brink, L. M D. Delbridge, T. Pedrazzini, F. L Rosenfeldt, and S. Pepe
Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2007; 8(4): 153 - 159.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
J. Weil, O. Zolk, J. Griepentrog, U. Wenzel, W. H. Zimmermann, and T. Eschenhagen
Alterations of the preproenkephalin system in cardiac hypertrophy and its role in atrioventricular conduction
Cardiovasc Res, February 1, 2006; 69(2): 412 - 422.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. M. Firoved, G. F. Miller, M. Moayeri, R. Kakkar, Y. Shen, J. F. Wiggins, E. M. McNally, W.-J. Tang, and S. H. Leppla
Bacillus anthracis Edema Toxin Causes Extensive Tissue Lesions and Rapid Lethality in Mice
Am. J. Pathol., November 1, 2005; 167(5): 1309 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Prinster, C. Hague, and R. A. Hall
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-D. Schluter and K. C Wollert
Synchronization and integration of multiple hypertrophic pathways in the heart
Cardiovasc Res, August 15, 2004; 63(3): 367 - 372.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.